Lecci A, Birder L A, Meini S, Catalioto R M, Tramontana M, Giuliani S, Criscuoli M, Maggi C A
Menarini Ricerche Pharmacology Department, via Rismondo 12 A, 50131 Firenze, Italy.
Br J Pharmacol. 2000 May;130(2):331-8. doi: 10.1038/sj.bjp.0703309.
Prostanoids, generated from cyclooxygenase (COX) isoenzymes, play a role in the physiological function of the lower urinary tract and are important mediators of inflammatory hyperalgesia. The present work evaluates the effects of the COX-1/COX-2 inhibitor dexketoprofen as well as of a selective COX-2 inhibitor, NS-398, on urodynamic function following endotoxin (LPS) or cyclophosphamide (CYP)-induced inflammation of the urinary bladder. The application of arachidonic acid (330 microgram rat(-1)) onto the serosal surface of the urinary bladder in control rats elicited bladder contractions which could be blocked in a dose-dependent manner by dexketoprofen (0.1 - 3 mg kg(-1), i.v.) but not by NS-398 (0.2 - 6 mg kg(-1), i.v. ). Dexketoprofen (3 mg kg(-1), i.v.) decreased the micturition frequency and increased the pressure threshold for triggering the micturition either when administered within 15 min or 3 h following surgery in control animals. NS-398 (6 mg kg(-1), i.v.) decreased the micturition frequency and increased the pressure threshold when administered 3 h but not 15 min following surgery. Administration of LPS (2 mg kg(-1), i.v., 90 - 120 min) increased both the micturition frequency and the pressure threshold for triggering the micturition reflex. Changes in urodynamic parameters induced by LPS were prevented by doses of either dexketoprofen (1 mg kg(-1), i.v.) or NS-398 (2 mg kg(-1), i.v.) which were ineffective in control animals. Pretreatment with CYP (150 mg kg(-1), i.p., 48 h) increased the micturition frequency, pressure threshold, and the minimal intravesical pressure but decreased the mean amplitude of micturition contractions. In CYP-treated rats, dexketoprofen (1 mg kg(-1), i.v.) or NS-398 (2 mg kg(-1), i.v.) blocked the CYP-induced urodynamic changes with exception of the micturition contraction amplitude. These results indicate that COX-1 may be involved in modulating the threshold for activating the micturition reflex in the normal rats and also demonstrates that inhibition of COX-2 prevents or reverses the urodynamic changes associated with bladder inflammation induced either by surgery, LPS or CYP treatments.
由环氧化酶(COX)同工酶生成的前列腺素在膀胱的生理功能中发挥作用,并且是炎性痛觉过敏的重要介质。本研究评估了COX-1/COX-2抑制剂右酮洛芬以及选择性COX-2抑制剂NS-398对内毒素(LPS)或环磷酰胺(CYP)诱导的膀胱炎症后尿动力学功能的影响。在对照大鼠中,将花生四烯酸(330微克/大鼠)应用于膀胱浆膜表面会引发膀胱收缩,右酮洛芬(0.1 - 3毫克/千克,静脉注射)可呈剂量依赖性地阻断这种收缩,但NS-398(0.2 - 6毫克/千克,静脉注射)则不能。右酮洛芬(3毫克/千克,静脉注射)在对照动物手术后15分钟或3小时内给药时,可降低排尿频率并提高触发排尿的压力阈值。NS-398(6毫克/千克,静脉注射)在手术后3小时而非15分钟给药时,可降低排尿频率并提高压力阈值。静脉注射LPS(2毫克/千克,90 - 120分钟)可增加排尿频率以及触发排尿反射的压力阈值。LPS诱导的尿动力学参数变化可被右酮洛芬(1毫克/千克,静脉注射)或NS-398(2毫克/千克,静脉注射)的剂量所阻止,而这些剂量在对照动物中无效。腹腔注射CYP(150毫克/千克,48小时)预处理可增加排尿频率、压力阈值和膀胱内最小压力,但会降低排尿收缩的平均幅度。在CYP处理的大鼠中,右酮洛芬(1毫克/千克,静脉注射)或NS-398(2毫克/千克,静脉注射)可阻断CYP诱导的尿动力学变化,但排尿收缩幅度除外。这些结果表明,COX-1可能参与调节正常大鼠中激活排尿反射的阈值,并且还表明抑制COX-2可预防或逆转与手术、LPS或CYP处理诱导的膀胱炎症相关的尿动力学变化。